Use of iron hemoprotein for treating pathogenic syndrome caused by nitric oxide overproduction
US5900403A · kind A · utility
2Cited by
11References
16Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 2, 1997 |
| Grant date | May 4, 1999 |
| Priority date | — |
| Expiry date | Oct 2, 2017 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention is directed to a method for the prophylaxis or treatment of an animal for deleterious physiological effects such as systemic hypotension caused by nitric oxide production induced by a biological response modifier. Examples of such biological response modifiers include but are not limited to a cytokine and an endotoxin. The invention is also direction to a method for the treatment of septic shock.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.